ADDI at CTAD 2022

ADDI is a proud sponsor of CTAD Clinical Trial on Alzheimer's Disease. Key leaders will be discussing progress in Alzheimer's therapeutic trials.

Our Director of Partnerships and Business Development Patrick Brannelly and our Director of Partnerships & Scientific Strategy Matthew Clement are attending; let us know if you're here!